BCL2 and thyroid gland carcinoma: BCL2 was generally downregulated in tumor tissues, and this trend became more pronounced as the disease progressed, so BCL2 also has a potential to be a dynamic signal for estimating the progression and prognosis of thyroid cancer (Fig. 6b, c).